{"name":"Ironwood Pharmaceuticals","slug":"ironwood","ticker":"IRWD","exchange":"NASDAQ","domain":"ironwoodpharma.com","description":"Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.","hq":"Boston, MA","founded":0,"employees":"100","ceo":"Tom McCourt","sector":"Gastroenterology","stockPrice":3.56,"stockChange":0.1,"stockChangePercent":2.89,"marketCap":"$580M","metrics":{"revenue":620000000,"revenueGrowth":-47.3,"grossMargin":67.9,"rdSpend":95136000,"netIncome":24017000,"cash":215456000,"dividendYield":0,"peRatio":23.7,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Linzess patent cliff ($234.6M at risk)","drug":"Linzess","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Microgestin®","genericName":"Microgestin®","slug":"microgestin","indication":"Oral contraception for prevention of pregnancy","status":"marketed"},{"name":"IW-6118","genericName":"IW-6118","slug":"iw-6118","indication":"Other","status":"phase_2"},{"name":"MD-1100 Acetate","genericName":"MD-1100 Acetate","slug":"md-1100-acetate","indication":"Other","status":"phase_2"},{"name":"XOI","genericName":"XOI","slug":"xoi","indication":"Chronic idiopathic constipation","status":"marketed"}]}],"pipeline":[{"name":"Microgestin®","genericName":"Microgestin®","slug":"microgestin","phase":"marketed","mechanism":"Microgestin is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of norethindrone (progestin) and ethinyl estradiol (estrogen).","indications":["Oral contraception for prevention of pregnancy"],"catalyst":""},{"name":"IW-6118","genericName":"IW-6118","slug":"iw-6118","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MD-1100 Acetate","genericName":"MD-1100 Acetate","slug":"md-1100-acetate","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"XOI","genericName":"XOI","slug":"xoi","phase":"marketed","mechanism":"XOI is a guanylate cyclase-C (GC-C) agonist that increases intracellular cGMP in intestinal epithelial cells to promote fluid secretion and bowel motility.","indications":["Chronic idiopathic constipation","Irritable bowel syndrome with constipation (IBS-C)"],"catalyst":""}],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Ironwood Pharmaceuticals reported its fourth quarter and full year 2023 financial results, with net product sales of $234.6 million for the year.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Ironwood Pharmaceuticals Announces Collaboration with AbbVie to Develop and Commercialize Linaclotide for the Treatment of Gastroparesis","summary":"Ironwood Pharmaceuticals announced a collaboration with AbbVie to develop and commercialize linaclotide for the treatment of gastroparesis.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"FDA Approves Linaclotide/Lactulose for the Treatment of Irritable Bowel Syndrome with Constipation in Adults","summary":"The FDA approved linaclotide/lactulose for the treatment of irritable bowel syndrome with constipation in adults.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxON2l1QTdxZGVxbGFGWVI4cy1iUGNnUUZmQ2wwQnJNV19lLXBqNDNmaklYcEQ5OXJrX3B2cXRfd2h2U2JGWDItVml0QzVRUm5wSHAxcVkxSWtyRzJFRHhPSnZfUnF4WUt1ODd6VmowNEZqNTV2QnpINi1FLWVzbi1tMW9jdUV0MzFHS0NWS2s0TE5OYlZZd0dncEJmdUhLOU5kX2kxc0ItelVJYzZjMmR0blo0SkNhUGY4MXlURDBtek03cDh5UXJKMEpCQUR6MlZzemd4Z25vQ2dQUQ?oc=5","date":"2026-03-20","type":"deal","source":"The Globe and Mail","summary":"Craig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD) - The Globe and Mail","headline":"Craig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD)","sentiment":"neutral"},{"date":"2026-03-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPaUhYdndYZzVJTE9jQ0VUXzh3RkRBUnNCMjhjT0xiclJZRnUxRWdIS1U4UFZIZWplMHpmLUNSVjVJT0dWYU9HYjNhZ2JoZDAzQm9rUUZrZmJLX0dMUktkbzc5OENLMks0S0VQUjdrclhNQmlBcHprTWxKVHlSZENaUkpUUm04TVRWbkR2WkVPTTJxTjRqTEhIekc0S3pvcERjaWl3eGhYdzJHWi1vbDBCeGd3QzZuTnZSUUxDLUxqWnZScjYtcktJLVFKNlFYc21QeWtpSDNPVkhZa2Yzblc1WkFycEdCY2I5RmVMam5XUTVoZEdlLXJlbGhvRE5mcHlF?oc=5","date":"2026-03-04","type":"pipeline","source":"Ironwood Pharmaceuticals","summary":"Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Ironwood Pharmaceuticals","headline":"Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNSUZJODlqZDh6SGwycjd0aXNyVDFDUTJWc2RuYjQwMThNM1kzdVctQlJYenhsbXROeDRQQzZUVmR6VkRKOWFnNmVGb0c3YkZjQXExcGFGTnc1SXhaT2ZMR0Eza3dySDNJSmFPWGRGbTRJYVFxWkRlVC1TLU5hQkNMS2N4LTJybmNxZFlaMzZndw?oc=5","date":"2026-02-25","type":"earnings","source":"Yahoo Finance","summary":"Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance","headline":"Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNQ1hpbEZhUEM4UXFzdGVtZG5vRG0xNlR6MG1xRldKemZSdEI1d2pYMXlJRElaUTh1VXZPRy1Bb1B2MEtLNU9IRUxvV1JOSklEdkpwZzBHeVV5ZTlfajU1aU9ZMjNNNmViMzJvRUp6clFBWUZpYzRNY1RGelJaWTNfcFQ4SE8xVGcxT2FvdlRSRENkaURObDF6M3loZWZqMmozTzZiOXowbDFtTEJ1WEtPVEM0cWNYWDlMaEZNc0lnYw?oc=5","date":"2026-02-23","type":"earnings","source":"TradingView","summary":"What's in Store for These 5 Medical Companies This Earnings Season? - TradingView","headline":"What's in Store for These 5 Medical Companies This Earnings Season?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPdHk2TkMyakNITHhYd0pKY084ZVViVDhNV25OZkxZd1ZZdlVxMWFLUk52UklidzFRZWUwa3J5NmxWQS1PWkZNbGVleDZrSHhRWXBKY1kxeEg4QnRheml6ZGQ0WVJaWVlocXY0LXV5UDBIRDg2MF9SaG5aM2F6YzdoOThYN1B2VWxZMURXeFN2LXFRVHVCQmNUNjhmYnR5TXFOVk5ab1hfYm5pTVh3ek5MblFpYWcyYWFhSE5SLTNId2hsMEpaQ3NLZnhpdmE3UllqR01uNS0tR3RNTDY0?oc=5","date":"2026-02-18","type":"earnings","source":"Business Wire","summary":"Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call - Business Wire","headline":"Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-06","type":"pipeline","source":"simplywall.st","summary":"Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st","headline":"Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Shares Bounce 32% But Its Business Still Trails The Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNQ2t5LVdkcUZza19QMlJVcVg4RHl0aHlrRDFGekVhUi1OcnUwdXQxYXgtdVJLSEg0ZXRUdGlWQlVnU3J5VDZYQkJFWTNRWl9vN2dONVhVaHY0THloVzFXSDVOcnhUSGF6cjFWc014dUFNZ2lHTUZ1WUM2MklBbUdVYVI4Nk0wbU9nX0d5WlM3Yk1mbHJJNlhwYTk3VFhpem5XaVl0WnN3?oc=5","date":"2025-12-30","type":"pipeline","source":"Kalkine Media","summary":"Ironwood Pharma (NASDAQ:IRWD) Nasdaq composite Biotech Watch - Kalkine Media","headline":"Ironwood Pharma (NASDAQ:IRWD) Nasdaq composite Biotech Watch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQeVlwZ0VMM3BUNGE3UzZBeHYybGR5QzZrNzdfZmhPRWhvdmFuSU95Y05vc1Z6WFdHcEpRY3lUMVd4WklYZVdVSjZTb3M5Y29PclRRQm5LRW95aEVQSW5wZHREQ0w5TnpFZ3gxbFhIMERTTWhpZDhZX19DNTZndmNNY0RZekttU0h3dFN3OHhDeXdLX1JucUQ3OXJCVC0tT2RIeV9MSmhTaWpqZkpEZkRQNVVpUUhWWHlMeVk1NzZtbUVQV3VBZkN0eUdXTQ?oc=5","date":"2025-11-26","type":"pipeline","source":"Seeking Alpha","summary":"Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous H1 2025 (IRWD) - Seeking Alpha","headline":"Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous H1 2025 (IRWD)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-12","type":"earnings","source":"simplywall.st","summary":"Need To Know: Analysts Are Much More Bullish On Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenues - simplywall.st","headline":"Need To Know: Analysts Are Much More Bullish On Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNFNkaXBfdU91dFNBdkdHemVPNHYxY1pfYm9ZYW1Xdzk4ZFFoakRFOEk5d0JadktNM1NvNVZzOHg5ZE9zZkxXSmFhRUxPZDBVaUI3dENzS2UtbUJRV2pYYXR3eXk2czQ5ZzB0bDdISmU1V3JMVURLbU9kWEUyblNxUXI1STVkTXBsaDg0?oc=5","date":"2025-04-10","type":"pipeline","source":"Yahoo Finance","summary":"Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - Yahoo Finance","headline":"Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNRDFKUFN4YU0yM1l1Z1RVQnNubzJMYnQ3V3Nac2pKM3dxSXNBWGRyWll2MU9rd1FYYjBKdkNaSHBvdl9hdzdyNzBTUkdYVHV5bkpST2g4MUp3ZVVpWlJFdnItTmpmMkhIeXJIWEt1WXF3WVlhLVZXZVhWbnhwZWVYejBfSjZIbEd0T0J4R0hTVW5YZw?oc=5","date":"2025-01-31","type":"pipeline","source":"The Pharma Letter","summary":"Investors irked by Ironwood cuts to future-proof company - The Pharma Letter","headline":"Investors irked by Ironwood cuts to future-proof company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBpMkJrcjJNRVJFaFFEVzhrQl9rZ0E5MTNzQjlTemxwRGpzbUxUUzlDTjNJNnBXQjZreEZvVElHdjVYOTdWVUkyTU9pLXV3N2N1?oc=5","date":"2024-03-03","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"}],"patents":[{"drugName":"Linzess","drugSlug":"linaclotide","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":234600000}],"drugCount":4,"phaseCounts":{"marketed":2,"phase_2":2},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Allergan","AstraZeneca","Takeda"],"therapeuticFocus":["Gastroenterology"],"financials":{"source":"sec_edgar+yahoo","revenue":298276000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":298276000,"period":"2017-12-31"},{"value":94208000,"period":"2017-12-31"},{"value":86825000,"period":"2017-09-30"},{"value":65077000,"period":"2017-06-30"},{"value":52166000,"period":"2017-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":95136000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":24017000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":396901000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":100,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":3.56,"previousClose":3.46,"fiftyTwoWeekHigh":5.78,"fiftyTwoWeekLow":0.53,"fiftyTwoWeekRange":"0.53 - 5.78","fiftyDayAverage":3.96,"twoHundredDayAverage":2.5,"beta":0.17,"enterpriseValue":946527744,"forwardPE":2.4,"priceToBook":-2.21,"priceToSales":1.96,"enterpriseToRevenue":3.2,"enterpriseToEbitda":7.85,"pegRatio":0,"ebitda":120640000,"ebitdaMargin":40.7,"freeCashflow":111571128,"operatingCashflow":127044000,"totalDebt":597801984,"debtToEquity":0,"currentRatio":1.13,"returnOnAssets":19.9,"returnOnEquity":0,"analystRating":"","recommendationKey":"none","numberOfAnalysts":4,"targetMeanPrice":6.1,"targetHighPrice":10,"targetLowPrice":3.7,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":3,"institutionHeldPercent":91.7,"sharesOutstanding":163058316,"floatShares":125579362,"sharesShort":13703587,"shortRatio":4.49,"shortPercentOfFloat":8.4,"epsTrailing":0.15,"epsForward":1.46,"revenuePerShare":1.83,"bookValue":-1.61,"officers":[{"age":68,"name":"Mr. Thomas A. McCourt","title":"CEO & Director"},{"age":49,"name":"Mr. John  Minardo","title":"Senior VP, Chief Legal Officer & Secretary"},{"age":66,"name":"Dr. Michael  Shetzline M.D., Ph.D.","title":"Chief Medical Officer, Senior VP and Head of Research & Drug Development"},{"age":36,"name":"Mr. Gregory  Martini","title":"Senior VP, CFO & Investor Relations"},{"age":43,"name":"Mr. Ronald  Silver","title":"Senior VP, Corporate Controller & Principal Accounting Officer"},{"age":null,"name":"Dr. Rosario  Lobrutto M.B.A., M.S., Ph.D.","title":"VP & Global Head of Technical Operations"},{"age":52,"name":"Ms. Tammi  Gaskins","title":"Senior Vice President & Chief Commercial Officer."},{"age":null,"name":"Mr. Jeff  Ruberti","title":"Chief Strategy Officer"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://ironwoodpharma.com","phone":"617 621 7722"}}